Christoph Schramm

22.2k total citations · 4 hit papers
232 papers, 10.0k citations indexed

About

Christoph Schramm is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Christoph Schramm has authored 232 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Hepatology, 127 papers in Epidemiology and 57 papers in Surgery. Recurrent topics in Christoph Schramm's work include Liver Diseases and Immunity (156 papers), Liver Disease Diagnosis and Treatment (117 papers) and Pediatric Hepatobiliary Diseases and Treatments (34 papers). Christoph Schramm is often cited by papers focused on Liver Diseases and Immunity (156 papers), Liver Disease Diagnosis and Treatment (117 papers) and Pediatric Hepatobiliary Diseases and Treatments (34 papers). Christoph Schramm collaborates with scholars based in Germany, United Kingdom and United States. Christoph Schramm's co-authors include Ansgar W. Lohse, Peter R. Galle, Ulrich Beuers, Gideon M. Hirschfield, Johannes Herkel, Christina Weiler‐Normann, Samuel Huber, David Jones, Marco Marzioni and Christophe Corpechot and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Immunity.

In The Last Decade

Christoph Schramm

215 papers receiving 9.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Simplified criteria for the diagnosis of autoimmune hepatitis†

2008 1.2k citations Christoph Schramm, Ansgar W. Lohse et al. profile →
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

2017 886 citations Gideon M. Hirschfield, Marco Marzioni et al. Journal of Hepatology profile →
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling

2004 590 citations Christoph Schramm et al. profile →
EASL Clinical Practice Guidelines on sclerosing cholangitis

2022 175 citations Olivier Chazouillères, Tom H. Karlsen et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christoph Schramm Germany	52	6.0k	5.3k	2.9k	1.8k	1.3k	232	10.0k
Mauro Podda Italy	60	5.4k 0.9×	4.6k 0.9×	4.1k 1.4×	910 0.5×	1.6k 1.2×	276	10.1k
Calogero Cammà Italy	62	7.5k 1.2×	8.4k 1.6×	2.3k 0.8×	298 0.2×	1.3k 1.0×	271	12.0k
Yoichi Hiasa Japan	43	3.9k 0.6×	4.2k 0.8×	1.2k 0.4×	790 0.4×	746 0.6×	406	7.2k
Carlos O. Esquivel United States	55	5.2k 0.9×	2.6k 0.5×	6.2k 2.1×	717 0.4×	1.2k 0.9×	375	10.6k
Annarosa Floreani Italy	46	4.2k 0.7×	4.0k 0.8×	2.0k 0.7×	414 0.2×	895 0.7×	242	6.5k
Stuart J. Knechtle United States	60	4.0k 0.7×	2.5k 0.5×	8.1k 2.8×	3.4k 1.9×	1.1k 0.9×	402	14.4k
Jürgen Klempnauer Germany	50	3.4k 0.6×	2.2k 0.4×	4.8k 1.6×	670 0.4×	1.6k 1.2×	296	8.7k
Shinichi Miyagawa Japan	47	4.1k 0.7×	2.3k 0.4×	5.0k 1.7×	454 0.3×	2.6k 2.0×	279	9.9k
Henri Kreis France	55	1.5k 0.3×	2.4k 0.4×	3.2k 1.1×	1.2k 0.7×	1.5k 1.2×	217	10.1k
Stefan Lindgren Sweden	46	2.2k 0.4×	2.7k 0.5×	1.9k 0.7×	594 0.3×	389 0.3×	165	6.4k

Countries citing papers authored by Christoph Schramm

Since Specialization

Citations

This map shows the geographic impact of Christoph Schramm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Schramm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Schramm more than expected).

Fields of papers citing papers by Christoph Schramm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Schramm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Schramm. The network helps show where Christoph Schramm may publish in the future.

Co-authorship network of co-authors of Christoph Schramm

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Schramm. A scholar is included among the top collaborators of Christoph Schramm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Schramm. Christoph Schramm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liwinski, Timur, Matthias K. Auer, Johanna Schröder, et al.. (2024). Gender-affirming hormonal therapy induces a gender-concordant fecal metagenome transition in transgender individuals. BMC Medicine. 22(1). 346–346. 5 indexed citations

Papp, Mária, Nóra Sipeki, Richard Taubert, et al.. (2024). Unmet needs in autoimmune hepatitis: Results of the prospective multicentre European Reference Network Registry (R‐LIVER). Liver International. 44(10). 2687–2699. 5 indexed citations

Oo, Ye Htun, Mária Papp, Benedetta Terziroli Beretta‐Piccoli, et al.. (2024). THU-113 Optimizing thiopurine therapy in autoimmune hepatitis (AIH): a multi-center study on monitoring metabolite profiles and co-therapy with allopurinol. Journal of Hepatology. 80. S316–S316. 1 indexed citations

Hartl, Johannes, Malte H. Wehmeyer, Marcial Sebode, et al.. (2023). Right and left liver lobe biopsies by minilaparoscopy reveal clinically significant sampling error in staging and grading of autoimmune hepatitis. Liver International. 43(6). 1269–1276. 6 indexed citations

Poetter‐Lang, Sarah, Alina Messner, Nina Bastati, et al.. (2023). Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study. European Radiology. 33(12). 9022–9037. 3 indexed citations

Casar, Christian, Dorothee Schwinge, Christoph Schramm, et al.. (2023). Human γδ T cell identification from single-cell RNA sequencing datasets by modular TCR expression. Journal of Leukocyte Biology. 114(6). 630–638. 6 indexed citations

Hartl, Johannes, et al.. (2023). Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases. JHEP Reports. 5(12). 100898–100898.

Reuken, Philipp A., Matthias Reichert, Fabian Finkelmeier, et al.. (2023). Evaluation of Ultrasound-based Surveillance for Hepatocellular Carcinoma in Patients at Risk: Results From a German Multicenter Retrospective Cohort Study. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 2 indexed citations

Löwe, Bernd, Viola Andresen, Omer Van den Bergh, et al.. (2022). Persistent SOMAtic symptoms ACROSS diseases — from risk factors to modification: scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211). BMJ Open. 12(1). e057596–e057596. 61 indexed citations

10.

Casar, Christian, Max Preti, Philip Rosenstiel, et al.. (2022). Inflammatory type 2 conventional dendritic cells contribute to murine and human cholangitis. Journal of Hepatology. 77(6). 1532–1544. 13 indexed citations

11.

Zachou, Kalliopi, Simon Pape, Elmar Jaeckel, et al.. (2021). Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis. JHEP Reports. 3(4). 100321–100321. 27 indexed citations

12.

Marjot, Thomas, Gustav Buescher, Marcial Sebode, et al.. (2021). OTH-1 SARS-CoV-2 Infection in patients with autoimmune hepatitis. A7.2–A8. 1 indexed citations

13.

Marjot, Thomas, Gustav Buescher, Marcial Sebode, et al.. (2021). SARS-CoV-2 infection in patients with autoimmune hepatitis. Journal of Hepatology. 74(6). 1335–1343. 76 indexed citations

14.

Hartl, Johannes, Rosa Miquel, Kalliopi Zachou, et al.. (2020). Features and outcome of AIH patients without elevation of IgG. JHEP Reports. 2(3). 100094–100094. 34 indexed citations

15.

Martrus, Glòria, Sebastian Lunemann, Laura Richert, et al.. (2017). Proliferative capacity exhibited by human liver-resident CD49a+CD25+ NK cells. PLoS ONE. 12(8). e0182532–e0182532. 20 indexed citations

16.

Aabakken, Lars, Tom H. Karlsen, Jörg Albert, et al.. (2017). Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Journal of Hepatology. 66(6). 1265–1281. 68 indexed citations

17.

Demir, Münevver, Sonja Lang, Christoph Schramm, et al.. (2016). Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients. Medicine. 95(38). e4602–e4602. 7 indexed citations

18.

Schwinge, Dorothee, Antonella Carambia, Alexander Quaas, et al.. (2015). Testosterone Suppresses Hepatic Inflammation by the Downregulation of IL-17, CXCL-9, and CXCL-10 in a Mouse Model of Experimental Acute Cholangitis. The Journal of Immunology. 194(6). 2522–2530. 58 indexed citations

19.

Pannicke, Nadine, Martina Sterneck, Christine zu Eulenburg, et al.. (2010). LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS : AN ANALYSIS OF MEDICAL AND SURGICAL RISK FACTORS. Transplant International. 23. 26–26. 2 indexed citations

20.

Schramm, Christoph, Michaël Bubenheim, J.G. O’Grady, et al.. (2008). 106 LONG TERM OUTCOME OF PATIENTS TRANSPLANTED FOR AUTOIMMUNE HEPATITIS—ANALYSIS OF THE EUROPEAN LIVER TRANSPLANT REGISTRY. Journal of Hepatology. 48. S47–S47. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact